Literature DB >> 25644165

Kidney cancer: S1P--a promising target in sunitinib-resistant RCC.

Clemens Thoma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25644165     DOI： 10.1038/nrurol.2015.16

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Anti-S1P Antibody as a Novel Therapeutic Strategy for VEGFR TKI-Resistant Renal Cancer.

Authors:  Liang Zhang; Xiaoen Wang; Andrea J Bullock; Marcella Callea; Harleen Shah; Jiaxi Song; Kelli Moreno; Barbara Visentin; Douglas Deutschman; David C Alsop; Michael B Atkins; James W Mier; Sabina Signoretti; Manoj Bhasin; Roger A Sabbadini; Rupal S Bhatt
Journal:  Clin Cancer Res       Date:  2015-01-14       Impact factor: 12.531
  1 in total
  1 in total

1.  Dual modulation of MCL-1 and mTOR determines the response to sunitinib.

Authors:  Mohamed Elgendy; Amal Kamal Abdel-Aziz; Salvatore Lorenzo Renne; Viviana Bornaghi; Giuseppe Procopio; Maurizio Colecchia; Ravindran Kanesvaran; Chee Keong Toh; Daniela Bossi; Isabella Pallavicini; Jose Luis Perez-Gracia; Maria Dolores Lozano; Valeria Giandomenico; Ciro Mercurio; Luisa Lanfrancone; Nicola Fazio; Franco Nole; Bin Tean Teh; Giuseppe Renne; Saverio Minucci
Journal:  J Clin Invest       Date:  2016-11-28       Impact factor: 14.808
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.